Product image of Metformina Kern Pharma (Metformin Hydrochloride) supplied by GNH India

Metformina Kern Pharma

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina Kern Pharma (Metformin Hydrochloride)

Metformin, the active ingredient in Metformina Kern Pharma, is a biguanide presented as an oral tablet for oral use. It is used to improve glycaemic control in adults with type 2 diabetes mellitus and related glucose intolerance conditions. The drug works by reducing hepatic glucose output and enhancing peripheral insulin sensitivity.

GNH India supplies Metformina Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kern Pharma, S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformina Kern Pharma (metformin) is indicated for disorders of glucose metabolism and related endocrine conditions.

  • Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels.
  • Impaired glucose tolerance: helps delay progression to overt diabetes.
  • Polycystic ovary syndrome (PCOS): improves insulin resistance and may restore ovulatory function.

How It Works

  • Metformin belongs to the biguanide class and primarily inhibits hepatic gluconeogenesis, thereby decreasing endogenous glucose production. It also enhances insulin‑mediated peripheral glucose uptake in muscle and adipose tissue and modestly reduces intestinal glucose absorption, collectively improving glycaemic control without stimulating insulin secretion.

Side Effects

Metformina Kern Pharma may be associated with several adverse reactions.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or dyspepsia.
  • Diarrhoea: frequent loose stools, especially during treatment initiation.
  • Metallic taste: transient alteration in taste perception.
  • Loss of appetite: reduced desire to eat.
  • Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but potentially fatal accumulation of lactate.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic dysfunction: abnormal liver enzymes or hepatitis.
  • Vitamin B12 deficiency: may develop with long‑term therapy.
  • Pancreatitis: inflammation of the pancreas.
  • Hypoglycaemia: when combined with other glucose‑lowering agents.

Precautions & Warnings

Before initiating Metformina Kern Pharma, clinicians should consider several safety measures.

  • Renal function assessment: avoid use in severe renal impairment.
  • Hepatic function monitoring: caution in patients with liver disease.
  • Lactic acidosis risk: evaluate for conditions predisposing to hypoxia.
  • Elderly dosing: start at lower doses and titrate cautiously.
  • Concomitant medication review: assess for drugs that may increase metformin exposure.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Metformina Kern Pharma can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate renal dysfunction and lactic acidosis.
  • Cimetidine: can increase metformin plasma concentrations.
  • Alcohol excess: heightens risk of lactic acidosis.
  • Certain antivirals (e.g., didanosine): may potentiate toxicity.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Diuretics: can affect renal clearance of metformin.
  • ACE inhibitors or ARBs: monitor renal function and electrolytes.
  • Other antidiabetic agents: adjust dosing to prevent hypoglycaemia.
  • Warfarin: may require INR monitoring.

Frequently Asked Questions

Metformina Kern Pharma contains metformin, which is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus, to delay progression in people with impaired glucose tolerance, and, in some cases, to treat insulin resistance associated with polycystic ovary syndrome.

Metformin reduces the liver’s production of glucose, enhances the sensitivity of muscle and fat cells to insulin, and modestly decreases intestinal absorption of glucose. These actions lower both fasting and post‑prandial blood‑glucose levels without stimulating insulin secretion.

The exact dose of Metformina Kern Pharma is determined by the prescribing healthcare professional based on the individual’s clinical condition, renal function, and response to therapy. Dosage adjustments are made according to standard medical guidelines.

Metformin crosses the placenta and is classified as a pregnancy‑category drug only after risk‑benefit assessment. It may be continued during pregnancy for certain indications, such as gestational diabetes, under medical supervision. Limited data exist for breastfeeding, and a clinician should evaluate safety for mother and infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line therapy for type 2 diabetes and differs from sulfonylureas, which stimulate insulin release, and from insulin itself, which replaces the hormone. Metformin’s advantage lies in its low risk of hypoglycaemia, weight neutrality or modest loss, and cardiovascular benefit profile.

Metformina Kern Pharma should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability and potency.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets are swallowed whole with a glass of water. The exact timing and frequency are prescribed by the treating clinician.

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition that requires immediate medical attention. Other serious risks include severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, and, with long‑term use, vitamin B12 deficiency.

Metformina Kern Pharma is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with conditions predisposing to hypoxia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT